FARALLON CAPITAL MANAGEMENT LLC 13D/13G Filings for Protagonist Therapeutics, Inc. (PTGX)

FARALLON CAPITAL MANAGEMENT LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
4:18 pm
Sale		 2021-12-31 13G Protagonist Therapeutics, Inc.
PTGX		 FARALLON CAPITAL MANAGEMENT LLC 3,417,134
6.900%		 -507,866decrease
(-12.94%)		 Filing
2021-02-12
6:42 pm
Purchase		 2020-12-31 13G Protagonist Therapeutics, Inc.
PTGX		 FARALLON CAPITAL MANAGEMENT LLC 3,925,000
9.000%		 1,071,902increase
(+37.57%)		 Filing